Bao Yang

Dr. Bao Yang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Foods
Verified
Journal Article
Open access
PDF file
YTYing Tong
Ying Tong
ZSZhiyong She
Zhiyong She
XLXueting Lin
Xueting Lin
JLJichu Luo
Jichu Luo
XGXuan Guan
Xuan Guan
QZQisong Zhang
Qisong Zhang
As a highly disabling chronic inflammatory disease, rheumatoid arthritis (RA) necessitates novel interventions. Liupao tea is a traditional Chinese dark tea known for its favorable anti-inflammatory properties. This study aims to elucidate the active ingredients and action mechanisms underlying the therapeutic effects of Liupao tea extract (LPTE) in RA. LPTE was preliminarily characterized by LC-MS technology. Network pharmacology and molecular docking predicted anti-RA compounds, targets, and pathways, with key compounds identified using chemical standards. The effect of LPTE on the collagen-induced arthritis mouse model was evaluated through serum biochemical analysis, micro-CT imaging, and histopathological analyses. Integrated serum metabolomics, 16S rRNA sequencing, MetOrigin analysis, SCFA metabolomics, and quantitative real-time PCR elucidated gut–joint axis mechanisms. LPTE effectively attenuated RA symptoms by reducing bone destruction and joint inflammation. Notably, LPTE reshaped gut microbiota by enriching key families such as Monoglobaceae, Eggerthellaceae, and Desulfovibrionaceae, thereby promoting SCFA production. Increased SCFA levels enhanced intestinal barrier integrity and exerted joint-protective and anti-inflammatory effects by upregulating tight junction proteins and activating SCFA receptors. LPTE also modulated arachidonic acid metabolism by affecting key genes such as Alox5, Ptgs2, and Cbr1. These effects collectively reduced the levels of pro-inflammatory cytokines and increased the expression of anti-inflammatory cytokines in joints. Additionally, quercetin, luteolin, ellagic acid, and kaempferol were identified as major anti-RA bioactive compounds in LPTE. Taken together, this study provides preliminary evidence that LPTE mitigates RA by regulating the gut–joint axis mediated via fatty acid metabolism.

18 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JLJichu Luo
Jichu Luo
ZWZhijuan Wei
Zhijuan Wei
YTYuru Tan
Yuru Tan
YTYing Tong
Ying Tong
BYBao Yang
Bao Yang
QZQisong Zhang
Qisong Zhang
Background: Type 2 diabetes (T2D) has become a serious global public health concern. Liubao tea (LBT) has demonstrated beneficial effects on gut microbiota and glucose-lipid metabolism, holding promising therapeutic potential for T2D; however, its underlying mechanisms remain unclear. This study aims to elucidate the potential mechanisms of Liubao tea extract (LBTE) against T2D. Methods: LC-MS technology was used to identify the chemical components of LBTE and combined with network pharmacology and molecular docking to screen its potential active ingredients and targets for improving T2D. Therapeutic efficacy was assessed in high-fat diet/streptozotocin (HFD/STZ)-induced diabetic mice via serum biochemical analyses and histopathological examinations. Serum metabolomics, 16S rRNA sequencing, quantification of short-chain fatty acids (SCFAs), quantitative real-time PCR (qPCR), and antibiotic-treated pseudo-germ-free models were employed to elucidate the underlying mechanisms. Results: LBTE effectively reduced blood glucose levels and improved lipid metabolism, primarily by promoting hepatic glycogen synthesis and suppressing glycerophospholipid synthesis. LBTE also alleviated hepatic inflammation by modulating inflammatory cytokine expression. Additionally, LBTE reshaped the gut microbiota profiles by decreasing harmful bacteria and increasing SCFA-producing bacteria, resulting in elevated fecal SCFAs. SCFAs contributed to improving hepatic metabolism and inflammation, enhancing intestinal barrier function. Notably, these effects were abolished by antibiotic-induced microbiota depletion, confirming the microbiota-dependent mechanism of LBTE. Quercetin, luteolin, genistein, and kaempferol were considered as potential active ingredients contributing to the antidiabetic effects of LBTE. Conclusions: These findings provide novel perspectives on the viability of LBTE as a complementary strategy for T2D prevention and management.

3 December 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
XFXixing Fang
Xixing Fang
XYXiao Yang
Xiao Yang
CZChangyuan Zhou
Changyuan Zhou
DZDi Zeng
Di Zeng
ZHZehua Hu
Zehua Hu
YHYuanxin Hou
Yuanxin Hou
Panax japonicus C.A. Mey., belonging to the genus Panax in the Araliaceae family, is a perennial drug plant. Its rhizomes, known traditional Chinese medicine (TCM) as Zhujieshen (Panacis Japonici Rhizoma), have a long history spanning thousands of years. This review systematically summarizes the multitarget antitumor effects of Zhujieshen and its bioactive metabolites, such as total saponins (TSPJ) and specific chikusetsusaponins (IVa, IV, V). Preclinical studies demonstrate broad anticancer activities against lung, liver, cervical, ovarian, prostate, and colorectal cancers by promoting apoptosis, suppressing proliferation, inhibiting metastasis, and enhancing chemosensitivity. Pharmacological investigations reveal that these effects are mediated through modulation of key signaling pathways, including PI3K/Akt, PKCα-ERK1/2, TLR4/NF-κB, and Wnt/β-catenin, which act on molecular targets like MMP-2, MMP-9, and Caspase-3. This collective regulation reduces inflammatory cytokine secretion, curtails tumor growth and spread, and increases sensitivity to chemotherapy.

7 March 2026 in International Immunopharmacology
Verified
Journal Article
Closed access
HCHuantian Cui
Huantian Cui
FMFeitian Min
Feitian Min
HDHongyu Deng
Hongyu Deng
YWYuming Wang
Yuming Wang
HLHanzhou Li
Hanzhou Li
NWNing Wang
Ning Wang

31 August 2026 in Foods
Verified
Journal Article
Open access
PDF file
XYXiao Yang
Xiao Yang
SXSong Xu
Song Xu
YTYing Tong
Ying Tong
JLJichu Luo
Jichu Luo
XFXixing Fang
Xixing Fang
QZQisong Zhang
Qisong Zhang
(1) Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease associated with gut microbiota dysbiosis and metabolic perturbations. Although Liubao tea (LBT) has gastroprotective benefits, the precise mechanisms by which LBT extract (LBTE) alleviates UC by orchestrating microbial and metabolic homeostasis remain poorly understood. (2) Methods: A DSS-induced UC mouse model was used to evaluate LBTE efficacy. Serum pharmacochemistry, untargeted metabolomics, 16S rRNA sequencing, and targeted SCFA metabolomics were integrated to characterize absorbable active constituents, metabolic shifts, and gut microbiota landscapes. SCFA- and arachidonic acid metabolism-related targets were validated by RT-qPCR and Western blotting. PGF models and FMT were used to assess the causal role of gut microbiota in LBTE-mediated efficacy. (3) Results: LBTE preserved colon length and mucosal integrity while reducing IL-6, TNF-α, IL-1β, and oxidative stress. It enriched SCFA-producing genera and increased colonic butyric and valeric acids, activating GPR41/GPR109A signaling, upregulating ZO-1 and occludin, and strengthening the intestinal barrier. LBTE also downregulated PTGS2 and ALOX5, restored PTGS1 and CYP3A11, and inhibited NF-κB signaling. These effects were weakened in PGF mice but reproduced by FMT from LBTE-treated donors, confirming microbiota-dependent protection. (4) Conclusions: LBTE may serve as a complementary strategy for UC prevention and management.